Foster Dykema Cabot & Co’s CONMED CNMD Stock Holding History

Foster Dykema Cabot & Co’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-72	Closed	-$10K	–	340
2023 Q2	$10K	Buy	+72	New	+$8.79K	﹤0.01%	237

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Foster Dykema Cabot & Co's CNMD Position: Q3 2023 in Review

Foster Dykema Cabot & Co sold out of CONMED (CNMD) in Q3 2023, closing a stake of 72 shares — an estimated $10K sold.

Foster Dykema Cabot & Co first reported a position in CNMD in Q2 2023 and held it in 1 quarter. The position peaked at $10K in Q2 2023. 275 funds tracked by Wall St. Rank hold CNMD as of Q3 2023.

Foster Dykema Cabot & Co reported no remaining CONMED position as of Q3 2023 after selling out during the quarter.
Foster Dykema Cabot & Co sold 72 CONMED shares in Q3 2023, an estimated $10K.
Foster Dykema Cabot & Co first reported a position in CONMED in Q2 2023 and held it in 1 quarter.
Foster Dykema Cabot & Co's CONMED position peaked at $10K in Q2 2023.
275 funds tracked by Wall St. Rank held CONMED as of Q3 2023.

Based on Foster Dykema Cabot & Co's 13F filing for Q3 2023, filed 14 Nov 2023.